Angiodynamics (ANGO) Current Deferred Tax Assets (2011 - 2015)
Angiodynamics' (ANGO) quarterly Current Deferred Tax Assets came in at $3.9 million in Q3 2015, up 7.44% YoY from $3.7 million in Q3 2014, and down 9.72% on a QoQ basis from $4.4 million in Q2 2015.
Angiodynamics (ANGO) Current Deferred Tax Assets (2011 - 2015) Analysis & Trends
Angiodynamics (ANGO) has 5 years of Current Deferred Tax Assets data on file, last reported at $3.9 million in Q3 2015.
- Quarterly Current Deferred Tax Assets rose 7.44% year-over-year to $3.9 million in Q3 2015, while the trailing twelve-month figure through Aug 2015 was $3.9 million (up 7.44% YoY) and the FY2015 annual result came in at $4.4 million, down 5.64% from the prior year.
- Current Deferred Tax Assets slipped to $3.9 million in Q3 2015, from $4.4 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $6.9 million in Q3 2012 to a low of $2.6 million in Q1 2015.
- A 5-year average of $4.4 million and a median of $4.0 million in 2014 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2012 — Current Deferred Tax Assets soared 140.2% — and 2014, when it sank 43.72%.
- Tracing ANGO's Current Deferred Tax Assets over 5 years: stood at $2.9 million in 2011, then soared by 141.21% to $6.9 million in 2012, then decreased by 2.49% to $6.7 million in 2013, then plunged by 38.99% to $4.1 million in 2014, then dropped by 3.69% to $3.9 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $3.9 million (Q3 2015), $4.4 million (Q2 2015), and $2.6 million (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.21 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.60 Bn | 2.32 Bn |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn |
| 4 | Resmed | 33.73 Bn | 32.26 Bn | 861.22 Mn |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.81 Bn | 14.67 Bn | 735.40 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn |
| 10 | Angiodynamics | 651.96 Mn | 598.09 Mn | 46.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2015 | 3.94 Mn |
| Aug 31, 2015 | 3.94 Mn |
| May 31, 2015 | 4.36 Mn |
| May 31, 2015 | 4.36 Mn |
| Feb 28, 2015 | 2.64 Mn |
| Feb 28, 2015 | 2.64 Mn |
| Nov 30, 2014 | 4.09 Mn |
| Nov 30, 2014 | 4.09 Mn |
| Aug 31, 2014 | 3.67 Mn |
| Aug 31, 2014 | 3.67 Mn |
| May 31, 2014 | 4.63 Mn |
| May 31, 2014 | 4.63 Mn |
| Feb 28, 2014 | 3.66 Mn |
| Feb 28, 2014 | 3.66 Mn |
| Nov 30, 2013 | 6.71 Mn |
| Nov 30, 2013 | 6.71 Mn |
| Aug 31, 2013 | 6.52 Mn |
| Aug 31, 2013 | 6.52 Mn |
| May 31, 2013 | 6.59 Mn |
| May 31, 2013 | 6.59 Mn |